Breaking News, Collaborations & Alliances

MilliporeSigma, GenScript to Accelerate Cell and Gene Therapy Industrialization in China

Collaboration to build global-standard platform for plasmid and virus manufacturing in China

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

MilliporeSigma has signed a collaboration agreement with China-based GenScript focusing on plasmid and viral vector manufacturing.   The parties envision an alliance that will accelerate the industrialization and commercialization of cell and gene therapy in China. GenScript, a leading biotech company headquartered in Nanjing aims to create a global-standard platform of plasmid and virus manufacturing service in the country. MilliporeSigma plans to provide GenScript with comprehensive products...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters